HeartWorks and Mayo Clinic launch a clinical trial that involves surgically injecting lab-grown cardiac tissue—sourced from the patients’ skin cells—in people with congenital heart disease.
New to HeartWorks? Here’s Where to Start.
HeartWorks is preparing to treat congenital heart disease patients with personalized cardiac cell therapy grown from their own cells. Learn how the Your Heart Program is moving regenerative medicine from the lab into human application and how you can be part of it.
